StockNews.com Downgrades InfuSystem (NYSEAMERICAN:INFU) to Buy

StockNews.com lowered shares of InfuSystem (NYSEAMERICAN:INFU) from a strong-buy rating to a buy rating in a research note issued to investors on Monday.

InfuSystem Stock Up 2.8 %

INFU opened at $7.72 on Monday. The company has a market cap of $164.13 million, a price-to-earnings ratio of 257.42 and a beta of 1.24. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.95 and a quick ratio of 1.54. InfuSystem has a one year low of $7.42 and a one year high of $11.44.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in INFU. Punch & Associates Investment Management Inc. raised its stake in InfuSystem by 3.2% during the third quarter. Punch & Associates Investment Management Inc. now owns 939,918 shares of the medical instruments supplier’s stock valued at $9,061,000 after purchasing an additional 28,807 shares in the last quarter. Wasatch Advisors LP raised its holdings in shares of InfuSystem by 3.4% in the fourth quarter. Wasatch Advisors LP now owns 846,609 shares of the medical instruments supplier’s stock valued at $8,923,000 after acquiring an additional 27,881 shares in the last quarter. Ranger Investment Management L.P. boosted its position in InfuSystem by 4.7% during the 4th quarter. Ranger Investment Management L.P. now owns 689,842 shares of the medical instruments supplier’s stock valued at $7,271,000 after acquiring an additional 30,835 shares in the last quarter. First Eagle Investment Management LLC grew its position in shares of InfuSystem by 14.7% in the 4th quarter. First Eagle Investment Management LLC now owns 537,214 shares of the medical instruments supplier’s stock worth $5,662,000 after buying an additional 68,814 shares during the last quarter. Finally, Heartland Advisors Inc. increased its position in InfuSystem by 17.6% during the 3rd quarter. Heartland Advisors Inc. now owns 500,000 shares of the medical instruments supplier’s stock valued at $4,820,000 after buying an additional 75,000 shares in the last quarter. 71.13% of the stock is currently owned by institutional investors.

About InfuSystem

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.